Gabriel Tinoco Selected Research

pazopanib

1/2021	Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
1/2018	A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriel Tinoco Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 01/2011
7	Sarcoma (Soft Tissue Sarcoma) 04/2023 - 01/2015
3	Disease Progression 03/2023 - 01/2021
2	Fatigue 03/2024 - 03/2023
2	Diarrhea 03/2024 - 03/2023
2	Pain (Aches) 03/2024 - 03/2023
2	Nausea 03/2024 - 03/2023
2	Exanthema (Rash) 03/2024 - 03/2023
2	Liposarcoma 11/2023 - 01/2021
2	Chondrosarcoma 01/2015 - 01/2015
1	Vomiting 03/2024
1	Epithelioid Hemangioendothelioma 03/2024
1	Alopecia (Baldness) 03/2024
1	Pneumonia (Pneumonitis) 03/2024
1	Constipation 03/2024
1	Edema (Dropsy) 03/2024
1	Retroperitoneal liposarcoma 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023
1	Thrombocytosis (Thrombocythemia) 07/2023
1	Melanoma (Melanoma, Malignant) 05/2023
1	Hepatitis 05/2023
1	Aggressive Fibromatosis (Desmoid) 03/2023
1	Hypophosphatemia 03/2023
1	Thrombocytopenia (Thrombopenia) 05/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Polyradiculopathy 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Heart Failure 05/2017
1	Cardiac Arrhythmias (Arrythmia) 05/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Glioma (Gliomas) 01/2015
1	Chondroma (Enchondroma) 01/2015
1	Triple Negative Breast Neoplasms 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2011

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 05/2023 - 05/2020
3	RNA (Ribonucleic Acid)IBA 01/2024 - 05/2023
2	pembrolizumabIBA 07/2023 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2015
2	AntigensIBA 01/2023 - 01/2011
2	pazopanib FDA Link 01/2021 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2015 - 01/2015
2	EnzymesIBA 01/2015 - 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	Cell-Free Nucleic AcidsIBA 03/2024
1	TFXIBA 03/2024
1	Opiate AlkaloidsIBA 03/2024
1	trametinibIBA 03/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2023
1	palbociclibIBA 11/2023
1	Formaldehyde (Formol)FDA Link 05/2023
1	ParaffinIBA 05/2023
1	nirogacestatIBA 03/2023
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2023
1	ChromograninsIBA 01/2023
1	SynaptophysinIBA 01/2023
1	Keratins (Keratin)IBA 01/2023
1	VimentinIBA 08/2022
1	DesminIBA 08/2022
1	Phosphotransferases (Kinase)IBA 09/2021
1	Tyrosine (L-Tyrosine)FDA Link 09/2021
1	Sunitinib (Sutent)FDA Link 09/2021
1	larotrectinibIBA 01/2021
1	NivolumabIBA 06/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	LactamsIBA 05/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020
1	Circulating Tumor DNAIBA 11/2019
1	AGI-5198IBA 01/2015
1	alpha-hydroxyglutarateIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2013
1	Hormones (Hormone)IBA 01/2013

Therapy/Procedure

11	Therapeutics 01/2024 - 05/2017
6	Immunotherapy 05/2023 - 01/2011
5	Drug Therapy (Chemotherapy) 07/2023 - 01/2013
2	Radiotherapy 01/2022 - 01/2015
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2024
1	Adjuvant Chemotherapy 01/2021
1	Neoadjuvant Therapy 01/2021
1	Hepatectomy 01/2021
1	Precision Medicine 01/2018
1	Biological Therapy 01/2013